NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adage Capital Management LP10% Owner2025-10-16447$91.04
$40.69kSell
Adage Capital Management LP10% Owner2025-10-16308$132.19
$40.71kSell
Adage Capital Management LP10% Owner2025-10-1619,198$140.00
$2.69MSell
Adage Capital Management LP10% Owner2025-10-1612,600$90.00
$1.13MSell
Adage Capital Management LP10% Owner2025-10-161,363$92.03
$125.44kSell
Adage Capital Management LP10% Owner2025-10-16559$100.11
$55.96kSell
Adage Capital Management LP10% Owner2025-10-1627,287$101.00
$2.76MSell
Adage Capital Management LP10% Owner2025-10-16250,000$104.31
$26.08MSell
Adage Capital Management LP10% Owner2025-10-161,661$130.10
$216.09kSell
Adage Capital Management LP10% Owner2025-10-16487$131.64
$64.11kSell

1 of 4

PRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bsof Parallel Master Fund LP23.25%4,894,109$856.81MInsider
Stefan Vitorovic13.97%2,939,329$514.59MInsider
Janus Henderson Group PLC12.04%2,533,405$443.52MInstitution
Holdings A. Novo11.60%2,442,080$427.53MInsider
Adage Capital Management LP9.79%2,060,175$360.67MInsider
Adage Capital Partners GP LLC9.38%1,974,585$345.69MInstitution
Cormorant Asset Management LP7.72%1,625,000$284.49MInstitution
Blackrock Inc7.56%1,590,128$278.38MInstitution
Price T Rowe Associates Inc7.00%1,473,075$257.89MInstitution
Morgan Stanley5.83%1,226,339$214.70MInstitution

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX63.26%36.74%Net SellingNet Selling
CRNX89.09%10.91%Net BuyingNet Selling
NAMS74.13%25.87%Net SellingNet Selling
KYMR75.97%24.03%Net BuyingNet Selling
AKRO74.85%25.15%Net BuyingNet Buying

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 114.76% institutional shareholders, 66.64% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 23.25% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $929.98M.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.